American Gene Technologies® International Inc.

📍 Rockville, United States🗓 Founded 2007👥 24 employees💰 Last funded 2022
Biotechnology Research🌐 americangene.com
Website LinkedIn
American Gene Technologies® International Inc. (AGT™) is a private biotechnology company pursuing cures and treatments for infectious diseases, cancers, and monogenic disorders. AGT™s emerging gene and cell therapeutics programs are designed to: ✅ Create immunotherapy for HIV disease with gene-modified T cells ✅ Activate innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology ✅ Treat PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation ✅ Advance clinically to provide human proof of concept For over a decade, AGT™ has developed, tested, and banked thousands of lentiviral vectors that can be adapted to the specific needs of new target diseases. AGT™ has developed gene therapy for diseases using this rapid gene delivery platform. GENE THERAPIES AGT™’s platform allows it to pursue clinical “cures” for complex diseases. The company has developed patent-protected gene therapeutics that are breakthroughs in medicine. *** See our extensive award winning patents on our website *** HIV/AIDS Immunotherapy for HIV disease with gene-modified T cells IMMUNO-ONCOLOGY Activates innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology PHENYLKETONURIA (PKU) Treats PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation AGT™s Core Objectives ✔️ Leverage our lentivirus platform to create highly-effective targeted genetic medicines ✔️ Create solutions for patients across a spectrum of infectious diseases, cancers and inherited disorders ✔️ Collaborate with leading medical researchers from around the globe To learn more and get in touch with American Gene Technologies® Inc., contact us today at https://www.americangene.com/contact-us/
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
2007
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Germany
1
Investor activity2019–2022 · investors recorded per year
201912020120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in American Gene Technologies® International Inc.?
American Gene Technologies® International Inc. has 3 investors on record on gritt.io.
When did American Gene Technologies® International Inc. last raise funding?
The most recent investment in American Gene Technologies® International Inc. recorded on gritt.io was in 2022.
When was American Gene Technologies® International Inc. founded?
American Gene Technologies® International Inc. was founded in 2007.
What industry is American Gene Technologies® International Inc. in?
American Gene Technologies® International Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is American Gene Technologies® International Inc. based?
American Gene Technologies® International Inc. is headquartered in Rockville, United States.